Inflammatory Licensed hMSCs Exhibit Enhanced Immunomodulatory Capacity in a Biomaterial Mediated Manner.
暂无分享,去创建一个
[1] L. Hofbauer,et al. New insights into the role of glycosaminoglycans in the endosteal bone microenvironment , 2021, Biological chemistry.
[2] Qiuli Liu,et al. Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis , 2021, Frontiers in Cell and Developmental Biology.
[3] D. Serrano,et al. Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts. , 2021, Pharmacological research.
[4] B. Harley,et al. Glycosaminoglycan content of a mineralized collagen scaffold promotes mesenchymal stem cell secretion of factors to modulate angiogenesis and monocyte differentiation , 2021, bioRxiv.
[5] D. Mooney,et al. Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells. , 2020, Biomaterials.
[6] D. Mooney,et al. Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and trafficking , 2020, Science Advances.
[7] M. Stevens,et al. Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[8] Tong-Chuan He,et al. Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds , 2019, Science Advances.
[9] G. Almeida-Porada,et al. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning , 2018, Front. Immunol..
[10] H. Leemhuis,et al. A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects , 2018, Nature Communications.
[11] C. D. dos Santos,et al. Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases , 2018, Stem Cell Research & Therapy.
[12] H. Koo,et al. Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ , 2018, EBioMedicine.
[13] Li-Hsin Han,et al. Modeling Physiological Events in 2D vs. 3D Cell Culture. , 2017, Physiology.
[14] Ross A. Marklein,et al. Morphological features of IFN-γ–stimulated mesenchymal stromal cells predict overall immunosuppressive capacity , 2017, Proceedings of the National Academy of Sciences.
[15] J. Hua,et al. Interactions between mesenchymal stem cells and the immune system , 2017, Cellular and Molecular Life Sciences.
[16] D. Hursh,et al. In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter. , 2016, Cytotherapy.
[17] Joshua A. Zimmermann,et al. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon‐γ Within Three‐Dimensional Mesenchymal Stem Cell Constructs , 2016, Stem cells translational medicine.
[18] S. Thorpe,et al. The Effect of Gradations in Mineral Content, Matrix Alignment, and Applied Strain on Human Mesenchymal Stem Cell Morphology within Collagen Biomaterials , 2016, Advanced healthcare materials.
[19] B. Harley,et al. Nanoparticulate mineralized collagen scaffolds induce in vivo bone regeneration independent of progenitor cell loading or exogenous growth factor stimulation. , 2016, Biomaterials.
[20] Ping Jin,et al. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming , 2016, Oncotarget.
[21] J. Zhao,et al. Restoration of a Critical Mandibular Bone Defect Using Human Alveolar Bone-Derived Stem Cells and Porous Nano-HA/Collagen/PLA Scaffold , 2016, Stem cells international.
[22] Kristopher A Kilian,et al. Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices , 2015, Advanced healthcare materials.
[23] F. O'Brien,et al. Recapitulating endochondral ossification: a promising route to in vivo bone regeneration , 2015, Journal of tissue engineering and regenerative medicine.
[24] Georges Noel,et al. Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.
[25] Kalina Belemezova,et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. , 2014, World journal of stem cells.
[26] Stefan Przyborski,et al. Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro , 2014, Journal of anatomy.
[27] Wei Cao,et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.
[28] K. Nelson,et al. Comparison of four different allogeneic bone grafts for alveolar ridge reconstruction: a preliminary histologic and biochemical analysis. , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.
[29] M. Barbeck,et al. Potential lack of "standardized" processing techniques for production of allogeneic and xenogeneic bone blocks for application in humans. , 2014, Acta biomaterialia.
[30] B. Harley,et al. Structural and Biochemical Modification of a Collagen Scaffold to Selectively Enhance MSC Tenogenic, Chondrogenic, and Osteogenic Differentiation , 2014, Advanced healthcare materials.
[31] F. O'Brien,et al. Novel Microhydroxyapatite Particles in a Collagen Scaffold: A Bioactive Bone Void Filler? , 2014, Clinical orthopaedics and related research.
[32] M. Jeong,et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages , 2014, Experimental & Molecular Medicine.
[33] Tingting Wang,et al. Modulation of macrophage phenotype by cell shape , 2013, Proceedings of the National Academy of Sciences.
[34] B. Harley,et al. The use of bioinspired alterations in the glycosaminoglycan content of collagen-GAG scaffolds to regulate cell activity. , 2013, Biomaterials.
[35] B. Harley,et al. Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds. , 2013, Tissue engineering. Part A.
[36] Edmond J. Breen,et al. Analysis of in vitro secretion profiles from adipose-derived cell populations , 2012, Journal of Translational Medicine.
[37] L. Zhang,et al. Mesenchymal stem cells: a double-edged sword in regulating immune responses , 2012, Cell Death and Differentiation.
[38] B. Harley,et al. The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity. , 2011, Biomaterials.
[39] A. Xiang,et al. Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.
[40] F. O'Brien,et al. Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering , 2010, Journal of materials science. Materials in medicine.
[41] Christian Jungreuthmayer,et al. Development of a biomimetic collagen-hydroxyapatite scaffold for bone tissue engineering using a SBF immersion technique. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.
[42] L. Gibson,et al. Design of a multiphase osteochondral scaffold. II. Fabrication of a mineralized collagen-glycosaminoglycan scaffold. , 2009, Journal of biomedical materials research. Part A.
[43] L. Gibson,et al. Characterization of mineralized collagen-glycosaminoglycan scaffolds for bone regeneration. , 2008, Acta biomaterialia.
[44] A. Caplan. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.
[45] L. Gibson,et al. The effect of pore size on cell adhesion in collagen-GAG scaffolds. , 2005, Biomaterials.
[46] Cato T. Laurencin,et al. Bone-Graft Substitutes: Facts, Fictions, and Applications , 2001, The Journal of bone and joint surgery. American volume.
[47] S. Opal,et al. Anti-inflammatory cytokines. , 2000, Chest.
[48] Jacques Galipeau,et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] M Aguet,et al. The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.